Amgen Senior Associate Scientist - Oncology and Inflammation in South San Francisco, California
The Department of Oncology and Inflammation at Amgen in South San Francisco is seeking a highly motivated Senior Associate Scientist to perform research aimed at elucidating mechanisms of immune regulation of tumor development, with the goal of developing novel immunotherapies for cancer treatment.
The successful candidate will be an integral member of a dynamic and highly collaborative research team, comprised of members of the Inflammation and Oncology department and other functional areas such as Therapeutic Discovery and Medical Sciences.
The successful candidate is expected to make major scientific laboratory-based contributions to the research goals of the department using cutting edge technologies and in vitro and in vivo models, present their results in both internal and external forums, and participate in the writing of manuscripts for publication. Specific responsibilities include planning and performing laboratory experiments, analyzing data, and communicating results.
Master’s degree and 3 years scientific experience
Bachelor’s degree and 5 years scientific experience
Doctorate degree with research experience in immunology, cancer biology or cell biology
Technical expertise in one or more of the following areas: Cellular immunology, multi-color flow cytometry, complex in vitro primary cell models, molecular biology, in vivo mouse models of cancer and/or inflammation, bioinformatics analysis of large gene expression datasets
Demonstrated track record of independent critical thinking and scientific achievement in research exemplified by a strong publication record and/or significant contributions to a therapeutic development program
Knowledgeable, highly motivated, creative, and collaborative
Strong verbal and written communication skills. Ability to collaborate and troubleshoot to solve problems
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.